Lv4
418 积分 2026-01-15 加入
TREM2‐IGF1 Mediated Glucometabolic Enhancement Underlies Microglial Neuroprotective Properties During Ischemic Stroke
13天前
已完结
Microglial metabolic reprogramming in Alzheimer's disease: Pathways, mechanisms, and therapeutic implications
14天前
已完结
Microglial innate memory and epigenetic reprogramming in neurological disorders
14天前
已完结
A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease
14天前
已完结
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
14天前
已完结
Microglia energy metabolism: A new perspective on Alzheimer's disease treatment
14天前
已完结
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
14天前
已完结
Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
14天前
已完结
Lecanemab in Early Alzheimer’s Disease
14天前
已完结
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
14天前
已完结
皖公网安备34019202002308
